We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| BioNTech SE | NASDAQ:BNTX | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 102.30 | 102.50 | 103.57 | 0 | 01:00:00 |
From May 2022 to May 2024
--The European Commission is in talks with Pfizer and BioNTech to reduce the up to 500 million vaccine doses that it had committed to buying, in exchange for higher prices, Reuters reported, citing a source with knowledge of the talks.
--The agreement might also possibly include an extension of the deadline for delivery until the second half of 2024, Reuters said, citing the source.
--Negotiations are continuing and it isn't yet clear what the final outcome may be, according to the agency.
Full story: https://reut.rs/3wBavPY
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
January 27, 2023 08:35 ET (13:35 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year BioNTech Chart |
1 Month BioNTech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
